Opioid Sparing: Prescribing Less is Insufficient

December 12, 2020
Michael Murphy, MD, PhD | Christine Moore, PhD | Missy Vadnais | Christine Moore

This white paper analyzes how opioid-sparing benefits could help mitigate the risks associated with opioids and argues that the opioid-sparing therapy must not diminish the level of analgesia obtained.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Michael Murphy, MD, PhD
MEET THE AUTHOR

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer
LEARN MORE
Christine Moore, PhD
MEET THE AUTHOR

Christine Moore, PhD

Vice President, Neuroscience, Scientific Solutions
LEARN MORE